Short answer: for most SARMs the time of day matters far less than taking them at the same time every day. The best-studied ones have long half-lives: about 14–24 hours for ostarine, 24–36 hours for LGD-4033 and about 45 hours for RAD-140, so one daily dose keeps levels steady (EMERALD protocol, Basaria 2013, LoRusso 2022). Timing can still help with side effects: morning if a compound disturbs your sleep, with food or in the evening if it upsets your stomach. No study has compared dosing times for any SARM.
| Compound | Half-life | Practical timing |
|---|---|---|
| Ostarine (MK-2866) | ~14–24 h (Phase 1) | Once daily, any consistent time |
| LGD-4033 | 24–36 h | Once daily; the trial dosed it in the morning, fasted |
| RAD-140 | ~45 h | Once daily; earlier if it affects sleep |
| Andarine (S4) | 2.6–5.3 h in rats; human not established | Users split doses; vision effects reported |
| YK11, S23 | Not established | No data |
| MK-677 (not a SARM) | GH-raising effect lasts ~24 h | Many take it at night |
| Cardarine (not a SARM) | Not established in humans | Once daily in trials |
| Stenabolic / SR9009 (not a SARM) | Not established | Users avoid evenings (wakefulness) |
Source: Sarmguide compound database.
SARMs Have Side Effects
This is the part people gloss over. Trials of SARMs measured lower testosterone, lower HDL cholesterol and raised liver enzymes, and a systematic review of SARMs in healthy adults found 15 case reports of drug-induced liver injury (Vignali 2023). Users also report headaches, nausea, sleep changes, aggression and, with andarine, vision changes.
Timing can’t change hormonal, cholesterol or liver effects, which depend on dose and duration. It can help with the short-lived ones, such as an upset stomach or trouble sleeping. Everyone reacts differently: the original author of this page heard from readers who had insomnia on ostarine and others who slept more.
Best Time to Take Ostarine
Ostarine (MK-2866, enobosarm) is the most studied SARM. Its half-life was about 21–24 hours after one dose and 14–21 hours with daily dosing in Phase 1 studies (EMERALD protocol). It lowered total testosterone and HDL cholesterol at 1–3 mg a day in a trial of older adults (Dalton 2011), so it is not side-effect free.
Possible Side Effects
- Headache was the most common side effect in the 86-day trial, though also common on placebo
- Raised ALT (liver enzyme) in 5 of 24 on 3 mg
- Lower HDL and testosterone
- Nausea, insomnia, joint pain, hair shedding (user reports)
Solution
Take it once a day at a consistent time. If it disturbs your sleep, take it in the morning; if it makes you nauseous, try the evening or with food. Timing won’t affect the lipid, hormone or liver changes. More: ostarine fact sheet and ostarine dosage.
Best Time to Take Ligandrol
LGD-4033 (ligandrol) has a half-life of 24–36 hours and builds up about threefold over three weeks of daily dosing. Even 1 mg a day lowered testosterone, SHBG and HDL in 21 days (Basaria 2013).
Possible Side Effects
- Suppression of testosterone, SHBG and FSH (trial)
- Lower HDL (trial)
- Liver injury (case reports)
- Headaches, nausea, water retention, raised blood pressure (user reports)
Solution
Once a day at any consistent time. The trial gave it in the morning after an overnight fast. If you suspect it raises your blood pressure, measuring it regularly is the way to find out; timing around the gym won’t change it. Full details: when to take LGD-4033.
Best Time to Take RAD140
RAD-140 has the longest half-life of the common SARMs, about 45 hours (LoRusso 2022). It has never been tested for muscle in people; in its only trial, liver-enzyme rises were the most common side effect.
Possible Side Effects
- Liver-enzyme rises (AST 59%, ALT 45% of trial patients)
- Vomiting, loss of appetite (27% each in the trial, at high doses)
- Testosterone suppression (strong in monkeys)
- Aggression, headaches, hair shedding (user reports)
Solution
Once a day; morning or night makes little difference to blood levels. Take it with food if it upsets your stomach, and earlier in the day if it affects sleep. Taking it an hour before the gym has no basis with a 45-hour half-life. See RAD-140 morning or night.
Best Time to Take Andarine
Andarine (S4) was developed alongside ostarine but has no published human trials. Its half-life was 2.6–5.3 hours in rats (Kearbey 2004); the human value is not established.
Possible Side Effects
- Vision changes: yellow tint, trouble seeing in the dark (user reports, more at higher doses)
- Testosterone suppression (LH and FSH fell in rats)
- Hair shedding (user reports)
Solution
Users usually split it into two or three doses because of the short rat half-life. Some take the last dose at bedtime so any vision change is noticed before driving; don’t drive if your vision changes. The original author suggested skipping andarine for ostarine, which has human data. See S4 before and after and andarine vs ostarine.
Best Time To Take YK11
YK11 is a steroidal partial androgen-receptor agonist that has never been tested in people. Its half-life is not established (Piper 2018).
Possible Side Effects
- Brain inflammation and oxidative stress (rats, Dahleh 2023)
- Aggression, acne, hair loss, joint pain, nausea (user reports)
- Suppression (expected; not measured)
Solution
There is no data to base timing on. Users often take it before training or split it into two doses; neither has been tested. See YK11 dosage.
Best Time to Take S23
S-23 has only been studied in rats, where it strongly suppressed LH and, with estrogen, stopped sperm production (Jones 2009). Its human half-life is not established.
Possible Side Effects
- Testosterone suppression (rats; users nearly always run a PCT)
- Fertility (designed as a male contraceptive in rats)
- Night sweats, aggression, hair shedding, darker urine (user reports)
Solution
Users report taking it in the morning and drinking more water during the day because of night sweats and darker urine; that is anecdotal. See S23 dosage.
Best Time to Take MK-677
MK-677 (ibutamoren) is not a SARM but a growth hormone secretagogue. Its GH-raising effect lasts about 24 hours after a dose, and its plasma half-life has not been published (FDA briefing, 2024). It is not a PCT: in obese men it lowered total testosterone vs placebo (Svensson 1999).
Possible Side Effects
- Increased appetite: 67% vs 36% on placebo in a 12-month trial (Nass 2008)
- Water retention and swelling, muscle pain
- Higher fasting blood sugar and lower insulin sensitivity
Solution
Many people take it at night, partly so hunger peaks while asleep and partly because it changed sleep in a study: deep (stage IV) sleep rose about 50% and REM sleep more than 20% in young men (Copinschi 1997). If you are bulking, morning dosing makes the extra appetite useful. See MK-677 fact sheet and MK-677 side effects.
Best Time To Take Cardarine
Cardarine (GW501516) is not a SARM but a PPAR-delta agonist. The old version of this page called it the best endurance enhancer with practically no side effects. In fact, endurance gains have only been shown in mice (Narkar 2008), and GSK stopped its development after two-year animal studies found cancers in many organs (GSK letter, 2013). Its human half-life has not been published, so the claim that levels peak an hour after a dose is unverified. In trials it was given once daily at 2.5–10 mg (Olson 2012). See the cardarine fact sheet and cardarine half-life.
Best Time To Take Stenabolic
Stenabolic (SR9009) is a REV-ERB agonist, not a SARM, and has never been tested in people. Its human half-life is unknown; the “4–6 hours” often quoted has no published human source. Users take it in the morning or early afternoon because REV-ERB agonists increased wakefulness and reduced REM and deep sleep in mice (Banerjee 2014). It is not side-effect free: a 2026 case report describes acute liver failure needing a transplant in a 17-year-old after SR9009 use (Shams Bin Shaheen 2026). See SR9009 dosage.
Before or after a workout?
For the long half-life compounds (ostarine, LGD-4033, RAD-140), levels barely change over a day, so taking them right before training gives no measurable peak at the gym. No study has compared pre- and post-workout dosing for any SARM. Pick a time you can stick to, adjust for stomach or sleep side effects, and keep it consistent.
Conclusion
The best time to take SARMs is usually “the same time every day”. Ostarine, LGD-4033 and RAD-140 have half-lives of roughly one to two days, so time of day affects comfort (stomach, sleep) more than results. For compounds without human data, such as andarine, YK11, S23 and SR9009, any timing advice is guesswork. What timing can’t change are the effects that come with dose and duration: suppression, lower HDL and liver strain. Compare compounds in the SARMs database and check when each one takes effect in when do SARMs kick in.
Frequently asked questions
What is the best time to take SARMs?
The same time every dayEvidence: Trial
Ostarine, LGD-4033 and RAD-140 have half-lives of roughly 14 to 45 hours, so one daily dose keeps levels steady. No study has compared dosing times for any SARM.
Is it better to take SARMs at night or in the morning?
Never compared in studiesEvidence: Limited
Blood levels of long half-life SARMs barely change over a day. Timing can only help with short-lived side effects such as trouble sleeping or an upset stomach.
Should I take SARMs before or after a workout?
Little differenceEvidence: Limited
For long half-life SARMs such as ostarine, LGD-4033 and RAD-140, levels barely change over a day, and no study has tested pre- versus post-workout dosing.
Should SARMs be split into two doses?
Not the long-acting onesEvidence: Trial
Ostarine, LGD-4033 and RAD-140 were given once daily in trials. Users split andarine because of its 2.6–5.3 hour half-life in rats; human data are lacking.
When should I take MK-677?
Often at night; untestedEvidence: Human data
Many people take it at night so the extra hunger peaks while asleep. In young men it increased deep sleep about 50% and REM sleep more than 20%.
Will one cycle of SARMs hurt me?
It canEvidence: Trial
Even short trials found lower testosterone and HDL cholesterol, and liver injury has been reported after weeks to a few months of use. A review of healthy adults found 15 case reports of drug-induced liver injury.
Are SARMs legal?
No SARM is approvedEvidence: Law
Rules vary by country; in Australia, for example, they are prescription-only with possession controls. WADA bans them in sport at all times.
Sources
- EMERALD study protocol (ISRCTN12213700, University of Liverpool, version 6.0, 2021): a window of opportunity study of enobosarm in ER+/AR+ early breast cancer
- The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men
- A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer
- Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users
- The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
- Pharmacokinetics of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro- 3-trifluoromethyl-phenyl)-propionamide in rats, a non-steroidal selective androgen receptor modulator
- Studies on the in vivo metabolism of the SARM YK11: Identification and characterization of metabolites potentially useful for doping controls
- YK11 induces oxidative stress and mitochondrial dysfunction in hippocampus: The interplay between a selective androgen receptor modulator (SARM) and exercise
- Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception
- FDA Briefing Document, Pharmacy Compounding Advisory Committee, 29 October 2024: Ibutamoren Mesylate
- Discrepancy between serum leptin values and total body fat in response to the oral growth hormone secretagogue MK-677
- Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial
- Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man
- AMPK and PPARdelta agonists are exercise mimetics
- Health Canada: GW501516 – Serious risks associated with use of unauthorized product (GSK letter, 24 May 2013)
- Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome
- Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour
- Acute Liver Failure in an Adolescent Following Use of the Synthetic REV-ERB Agonist SR9009